Ann Rheum Dis. 2006 Sep;65(9):1158-62. Epub 2006 Mar 28.

Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.

Ravet N, Rouaghe S, Dodé C, Bienvenu J, Stirnemann J, Lévy P, Delpech M, Grateau G.

Source

Service de Médecine Interne, Hôpital Tenon, 4 rue de la Chine, 75970 Paris Cedex 20, Paris, France. nathalie.ravet@tnn.aphp.fr

Abstract

OBJECTIVE:

Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) has been associated with several mutations in the TNF receptor super family 1A (TNFRSF1A), including most cysteine substitutions. However, the nature of two substitutions, P46L and R92Q, remains a topic of discussion. The aim of this study was to assess the actual role of these two sequence variations in a series of patients with TRAPS.

METHODS:

The main clinical data of 89 patients with TRAPS have been prospectively registered on a standard form. 84 patients or members of families with recurrent episodes of inflammatory symptoms spanning a period of more than 6 months and harbouring a TNFRSF1A mutation were studied. Clinical data have been analysed according to the nature of the mutation-P46L, R92Q or others.

RESULTS:

P46L is often seen in patients from Maghreb and is associated with a mild phenotype. P46L appears as a polymorphism with a non-specific role in inflammation. R92Q is associated with a variable phenotype and presents as a low-penetrance mutation. Interpreting these results will require a comparison with clinical signs and genetic background.

PMID:: 16569687; [PubMed - indexed for MEDLINE]
PMCID:: PMC1798274

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

COLCHICINE - HSDB

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. [Medicine (Baltimore). 2002]
Review The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL. Medicine (Baltimore). 2002 Sep; 81(5):349-68.
Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. [Ann Rheum Dis. 2008]
Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH, Herold M, Schirmer M. Ann Rheum Dis. 2008 Sep; 67(9):1292-8. Epub 2008 Jan 7.
The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. [Am J Hum Genet. 2001]
The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, et al. Am J Hum Genet. 2001 Aug; 69(2):301-14. Epub 2001 Jul 6.
A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. [Rheumatology (Oxford). 2004]
A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H, Kawasaki E, Miyashita T, Tanaka F, Kamachi M, Izumi Y, Huang M, Tamai M, Origuchi T, Kawakami A, et al. Rheumatology (Oxford). 2004 Oct; 43(10):1292-9. Epub 2004 Jul 27.
Review [Tumor necrosis factor receptor superfamily 1A-associated periodic syndrome (TRAPS)]. [Rev Med Interne. 2003]
Review [Tumor necrosis factor receptor superfamily 1A-associated periodic syndrome (TRAPS)].
Hentgen V, Granel B, Dodé C, Cuisset L, Delpech M, Grateau G. Rev Med Interne. 2003 Dec; 24(12):781-5.

See reviews... See all...

Cited by 7 PubMed Central articles

Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). [J Exp Med. 2011]
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).
Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, Sack MN, Kastner DL, Siegel RM. J Exp Med. 2011 Mar 14; 208(3):519-33. Epub 2011 Jan 31.
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. [Arthritis Rheum. 2011]
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene.
Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federici S, Zulian F, Calcagno G, Tommasini A, Bossi G, Sormani MP, et al. Arthritis Rheum. 2011 Apr; 63(4):1141-50.
Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. [Proc Natl Acad Sci U S A. 2010]
Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ, Chae JJ, Ettinger R, de Koning HD, Cruz AC, et al. Proc Natl Acad Sci U S A. 2010 May 25; 107(21):9801-6. Epub 2010 May 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Clinical significance of P46L and R92Q substitutions in the tumour necrosis fact...
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.
Ann Rheum Dis. 2006 Sep ;65(9):1158-62. Epub 2006 Mar 28 .

PubMed
Retinoylation of the cAMP-binding regulatory subunits of type I and type II cAMP...
Retinoylation of the cAMP-binding regulatory subunits of type I and type II cAMP-dependent protein kinases in HL60 cells.
Arch Biochem Biophys. 1991 Nov 1 ;290(2):293-302.

PubMed
Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 ac...
Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis.
Proc Natl Acad Sci U S A. 2006 Apr 4 ;103(14):5484-9. Epub 2006 Mar 27 .

PubMed
Collagenase reserves in polymorphonuclear neutrophil leukocytes from synovial fl...
Collagenase reserves in polymorphonuclear neutrophil leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis.
Matrix. 1991 Aug ;11(4):296-301.

PubMed
A review of articular cartilage pathology and the use of glucosamine sulfate.
A review of articular cartilage pathology and the use of glucosamine sulfate.
J Athl Train. 2001 Oct ;36(4):413-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.

Source

Abstract

OBJECTIVE:

METHODS:

RESULTS:

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information